TY  - BOOK
AU  - Yacoub,Nejla
AU  -  Laperche,Blandine
TI  - Strategies of Large Pharmaceutical Groups in Dealing with Generic Drugs
PY  - 2010///.
							
N1  - 35
N2  - What are the strategies adopted by large pharmaceutical firms (Big Pharma) in dealing with the globalized generics competition? This paper focuses on the arbitration these firms make between knowledge-capital accumulation and knowledge-capital valorization strategies. The knowledge-capital is defined as the set of information, knowledge, know-how that a firm produces, acquires, combines and systemizes to be used in the value production process. Big Pharma are short term profit oriented, favoring the objective of valorization of their existing knowledge-capital while their objectives of accumulation of knowledge-capital are targeted on minor innovation. JEL codes: L12, L21, L65
UR  - https://shs.cairn.info/journal-innovations-2010-2-page-81?lang=en&redirect-ssocas=7080
ER  -